Literature DB >> 4058458

Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.

R C Griggs, J R Mendell, M H Brooke, G M Fenichel, J P Miller, M Province, R T Moxley, D Huntzinger, A Vaughn, M Cohen.   

Abstract

We have determined the value of creatine and pyruvate kinase (CK and PK) in carrier detection by evaluating 811 females in 73 families participating in the Collaborative Investigation of Duchenne Dystrophy. Thirty-nine obligate carriers, 244 normal controls (paternal females), as well as 76 possible carriers and 351 carrier suspects had three CK and PK specimens analyzed at a central laboratory. The CK and PK values varied with age in normals: both fell with age early in life, and CK rose after the fifth decade. Discriminant analysis indicated that the combination of mean CK and PK corrected for age yielded the best data for calculation of carrier probability. Using the best model, only 45% of obligate carriers could be identified at a false-positive rate of 2.5%. Daughters of obligate carriers have a disproportionate decline in CK and PK with age as compared to noncarrier females, suggesting that the rate of carrier detection will be higher in the first two decades. Our low rate of carrier detection, as compared to other studies, may reflect both the age of our obligate carrier population and the use of a control group that is more representative of the carrier population.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4058458     DOI: 10.1002/mus.880080111

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

1.  Myoglobin is a sensitive marker of increased muscle membrane vulnerability.

Authors:  M F Driessen-Kletter; G J Amelink; P R Bär; J van Gijn
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

2.  Clinical and Genetic Characterization of Female Dystrophinopathy.

Authors:  Seung Ha Lee; Jung Hwan Lee; Kyung A Lee; Young Chul Choi
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

3.  Three cases of manifesting female carriers in patients with Duchenne muscular dystrophy.

Authors:  Tae-Jin Song; Kyung-A Lee; Seong-Woong Kang; Hanna Cho; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2011-01       Impact factor: 2.759

4.  MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy.

Authors:  Sean C Forbes; Donovan J Lott; Richard S Finkel; Claudia Senesac; Barry J Byrne; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Neuromuscul Disord       Date:  2012-10-01       Impact factor: 4.296

5.  Sporadic lower limb hypertrophy and exercise induced myalgia in a woman with dystrophin gene deletion.

Authors:  D Malapert; D Recan; F Leturcq; J D Degos; R K Gherardi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

6.  Linkage analysis of polymorphisms within the DNA fragment XJ cloned from the breakpoint of an X;21 translocation associated with X linked muscular dystrophy.

Authors:  M W Thompson; P N Ray; B Belfall; C Duff; C Logan; I Oss; R G Worton
Journal:  J Med Genet       Date:  1986-12       Impact factor: 6.318

7.  Genetic analysis of dystrophin gene for affected male and female carriers with Duchenne/Becker muscular dystrophy in Korea.

Authors:  Bo Lyun Lee; Sook Hyun Nam; Jun Hwa Lee; Chang Seok Ki; Munhyang Lee; Jeehun Lee
Journal:  J Korean Med Sci       Date:  2012-02-23       Impact factor: 2.153

8.  Reassessing carrier status for dystrophinopathies.

Authors:  Tara M Newcomb; Kevin M Flanigan
Journal:  Neurol Genet       Date:  2016-10-05

9.  Phenotypic contrasts of Duchenne Muscular Dystrophy in women: Two case reports.

Authors:  Karen T Nozoe; Ricardo T Akamine; Diego R Mazzotti; Daniel N Polesel; Luís F Grossklauss; Sergio Tufik; Monica L Andersen; Gustavo A Moreira
Journal:  Sleep Sci       Date:  2016-08-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.